Medical Countermeasures New Insights Into Tularemia Pathogen May Inform Next-Generation Medical CountermeasuresGlobal Biodefense StaffMay 14, 2026
Medical Countermeasures When Mpox Strikes the Eye: A Case for Combination Antiviral TherapyGlobal Biodefense StaffApril 16, 2026
Medical Countermeasures Smallpox Preparedness Contracts Top $60 Million as U.S. and International Partners Bolster Biodefense StockpilesGlobal Biodefense StaffMarch 25, 2026
DARPA Selects Teams to Develop Vaccine Durability Prediction Model Medical Countermeasures January 13, 2023 …
Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding Industry News January 12, 2023 …
NISTCHO: New Living Reference Material for Producing Monoclonal Antibodies Medical Countermeasures January 12, 2023 …
Protection from Biothreats: DOD to Modernize Medical Countermeasures Development CBRNE January 10, 2023 …
DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development Industry News January 10, 2023 …
How Organ-on-a-chip Models Could Grease the Drug Development Pipeline Medical Countermeasures January 10, 2023 …
Texas Biomed at Forefront of Sudan ebolavirus Vaccine Development Medical Countermeasures December 27, 2022 …
Bavarian Nordic Awarded DoD Contract to Advance Equine Encephalitis Virus Vaccine Medical Countermeasures December 22, 2022 …
Los Alamos Researchers to Help Revolutionize Future of Vaccine Development Medical Countermeasures November 3, 2022 …
NIH Grant Will Expand National Swine Resource and Research Center Medical Countermeasures October 25, 2022 …
Study: Cash Incentives and Lotteries Do Little to Increase Adult Vaccinations Medical Countermeasures October 25, 2022 …
Stem Cell Research Gives New Clues on Ebola Virus Damage to Organs Medical Countermeasures September 9, 2022 …
NIH Begins Clinical Trial of Intradermal Monkeypox Vaccine Delivery to Expand Supply Medical Countermeasures September 8, 2022 …
Bavarian Nordic to Supply Additional Monkeypox Vaccine to EU Member States Industry News September 7, 2022 …
Arcturus Awarded $63.2M to Advance Self-amplifying mRNA Vaccine for Pandemic Influenza Response Industry News August 31, 2022 …
New Universal Flu Vaccine Offers Broad Protection Against Influenza A Virus Infections Medical Countermeasures July 17, 2022 …
